- Home
- PFIS vs MLTX Comparison
PFIS vs MLTX Comparison
Compare PFIS & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFIS
- MLTX
- Stock Information
- Founded
- PFIS 1905
- MLTX 2021
- Country
- PFIS United States
- MLTX Switzerland
- Employees
- PFIS N/A
- MLTX N/A
- Industry
- PFIS Major Banks
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- PFIS Finance
- MLTX Health Care
- Exchange
- PFIS Nasdaq
- MLTX Nasdaq
- Market Cap
- PFIS 523.7M
- MLTX 595.6M
- IPO Year
- PFIS N/A
- MLTX N/A
- Fundamental
- Price
- PFIS $46.17
- MLTX $10.75
- Analyst Decision
- PFIS
- MLTX Buy
- Analyst Count
- PFIS 0
- MLTX 9
- Target Price
- PFIS N/A
- MLTX $37.63
- AVG Volume (30 Days)
- PFIS 34.1K
- MLTX 11.0M
- Earning Date
- PFIS 11-04-2025
- MLTX 11-06-2025
- Dividend Yield
- PFIS 5.41%
- MLTX N/A
- EPS Growth
- PFIS 39.41
- MLTX N/A
- EPS
- PFIS 3.35
- MLTX N/A
- Revenue
- PFIS $165,604,000.00
- MLTX N/A
- Revenue This Year
- PFIS $70.81
- MLTX N/A
- Revenue Next Year
- PFIS $4.92
- MLTX N/A
- P/E Ratio
- PFIS $13.61
- MLTX N/A
- Revenue Growth
- PFIS 82.33
- MLTX N/A
- 52 Week Low
- PFIS $38.90
- MLTX $5.95
- 52 Week High
- PFIS $59.70
- MLTX $62.75
- Technical
- Relative Strength Index (RSI)
- PFIS 29.71
- MLTX 26.01
- Support Level
- PFIS $47.11
- MLTX $8.18
- Resistance Level
- PFIS $47.84
- MLTX $7.48
- Average True Range (ATR)
- PFIS 1.37
- MLTX 1.65
- MACD
- PFIS -0.33
- MLTX -1.41
- Stochastic Oscillator
- PFIS 9.62
- MLTX 8.43
About PFIS Peoples Financial Services Corp.
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.